Recent Finacing
Recent Raise
Chromis Therapeutics develops small-molecule antivirals for chronic hepatitis B, targeting cccDNA and other HBV lifecycle steps via a proprietary drug-design platform and in vitro core-assembly model.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor